SELECT LANGUAGE BELOW

Lung disease: This condition can also pose risks for younger individuals

Lung disease: This condition can also pose risks for younger individuals

Understanding COPD and Its Impact

Chronic obstructive pulmonary disease, known as COPD, ranks as the fourth leading cause of death globally, resulting in approximately 3.5 million fatalities in 2021 according to the World Health Organization.

In the U.S., about 6% of adults are affected, placing it among the top ten causes of death. The CDC reports a significant rise in cases with age—some estimates suggest that 20% to 25% of individuals over 70 may have this condition.

Interestingly, researchers are delving into what’s termed “young COPD,” which refers to cases diagnosed before the age of 50. A recent study published in NEJM Evidence identified that around 4.5% of adults under 50 had “young COPD,” linking it with an increased risk of hospitalization and early mortality.

It raises some questions: What causes COPD? What are the risk factors? And, how can those with this condition enhance their health outcomes?

Dr. Leana Wen, an emergency physician and clinical associate professor, shared her insights on this topic with CNN.

CNN: What is COPD and what are its risk factors?

Dr. Leana Wen: COPD encompasses a group of lung diseases that result in airflow limitation, significantly hindering breathing. The two most prevalent types are emphysema, which damages the lung’s air sacs, and chronic bronchitis, characterized by persistent inflammation and mucus production.

This chronic and progressive condition has no cure, but therapies can help manage symptoms and minimize flare-ups.

The primary risk factor for COPD is smoking, but others include secondhand smoke exposure and environmental pollutants. Individuals with asthma or a family history of the disease are also at a heightened risk.

CNN: How does the new study define young COPD?

Wen: The definition of “young COPD” varies by study. This recent research took a broader approach, encompassing nonsmokers as well.

They set specific criteria: a spirometry test showing airflow obstruction, a history of either significant smoking (10 or more pack years) or respiratory symptoms, and being aged between 18 to 49.

CNN: What does the study reveal about prognosis?

Wen: Researchers analyzed four groups from other studies, providing a diverse reflection of the U.S. population. They identified a 4.5% prevalence of young COPD.

Comparing outcomes, they found that those with young COPD faced more than 1.4 times the risk of dying before age 75 and were over 2.5 times more likely to be hospitalized or die from chronic lung disease.

CNN: Why might young COPD elevate mortality risk?

Wen: Studies demonstrate that even mild COPD correlates with higher mortality rates. This is often linked to previous smoking habits leading to cancer and cardiovascular diseases. Additionally, COPD significantly increases vulnerability to severe respiratory illnesses such as pneumonia and viruses, including Covid-19.

CNN: How can individuals with COPD improve health outcomes?

Wen: It’s crucial for patients to acknowledge their diagnosis. Some might dismiss symptoms like chronic coughing or breathlessness as normal signs of aging. In fact, many with COPD have never smoked. Early recognition and treatment are vital.

Common symptoms to watch for include recurrent lung infections, worsening shortness of breath, increased mucus production, and fatigue. Patients should consult their healthcare providers who might recommend spirometry testing.

Once diagnosed, treatment often includes lifestyle adjustments, primarily quitting smoking, along with staying active, minimizing exposure to pollutants, and possibly joining a pulmonary rehabilitation program.

Staying up to date with vaccinations is also critical, as individuals with COPD face a higher risk of severe illness from respiratory infections. They should discuss vaccinations related to pneumonia, Covid-19, influenza, and RSV with their doctors.

Finally, healthcare providers might prescribe medications to alleviate symptoms, including bronchodilators and anti-inflammatories, and will monitor for any signs of infection closely.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News